MMM

Prezzo 3M

MMM
$155,47
+$4,92(+3,26%)

*Data last updated: 2026-04-17 18:42 (UTC+8)

As of 2026-04-17 18:42, 3M (MMM) is priced at $155,47, with a total market cap of $79,29B, a P/E ratio of 26,32, and a dividend yield of 1,97%. Today, the stock price fluctuated between $152,21 and $156,38. The current price is 2,14% above the day's low and 0,58% below the day's high, with a trading volume of 1,56M. Over the past 52 weeks, MMM has traded between $137,63 to $177,42, and the current price is -12,37% away from the 52-week high.

MMM Key Stats

Yesterday's Close$151,24
Market Cap$79,29B
Volume1,56M
P/E Ratio26,32
Dividend Yield (TTM)1,97%
Dividend Amount$0,78
Diluted EPS (TTM)6,08
Net Income (FY)$3,25B
Revenue (FY)$24,94B
Earnings Date2026-04-21
EPS Estimate2,02
Revenue Estimate$6,00B
Shares Outstanding524,29M
Beta (1Y)1.158
Ex-Dividend Date2026-02-13
Dividend Payment Date2026-03-12

About MMM

3M Company operates as a diversified technology company worldwide. It operates through four segments: Safety and Industrial; Transportation and Electronics; Health Care; and Consumer. The Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. The Transportation and Electronics segment provides ceramic solutions; attachment tapes, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; and reflective signage for highway, and vehicle safety. The Healthcare segment offers food safety indicator solutions; health care procedure coding and reimbursement software; skin, wound care, and infection prevention products and solutions; dentistry and orthodontia solutions; and filtration and purification systems. The Consumer segment provides consumer bandages, braces, supports and consumer respirators; cleaning products for the home; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. The company was founded in 1902 and is based in St. Paul, Minnesota.
SectorIndustrials
IndustryConglomerates
CEOWilliam Brown
HeadquartersSaint Paul,MN,US
Official Websitehttps://www.3m.com
Employees (FY)60,50K
Average Revenue (1Y)$412,36K
Net Income per Employee$53,71K

3M (MMM) FAQ

What's the stock price of 3M (MMM) today?

x
3M (MMM) is currently trading at $155,47, with a 24h change of +3,26%. The 52-week trading range is $137,63–$177,42.

What are the 52-week high and low prices for 3M (MMM)?

x

What is the price-to-earnings (P/E) ratio of 3M (MMM)? What does it indicate?

x

What is the market cap of 3M (MMM)?

x

What is the most recent quarterly earnings per share (EPS) for 3M (MMM)?

x

Should you buy or sell 3M (MMM) now?

x

What factors can affect the stock price of 3M (MMM)?

x

How to buy 3M (MMM) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su 3M (MMM)

ponzi_poet

ponzi_poet

10 ore fa
Been watching 3M (MMM) lately and there's something pretty significant brewing here that could reshape the whole dividend aristocrat narrative around this stock. So here's the thing - 3M has held its dividend aristocrat status for over 60 years, consistently raising payouts to shareholders. That's actually impressive in this market. Right now it's yielding around 5.72%, which is honestly one of the juiciest yields in the industrial sector. But there's a massive shadow hanging over it. The company is dealing with roughly 300,000 claims related to defective foam earplugs sold to U.S. military personnel. The settlement talks are already underway, and analysts are estimating this could cost 3M somewhere north of 10 billion dollars. On top of that, there's a whole other litigation mess - PFAS chemical contamination lawsuits from municipalities. That's potentially another 10 billion in settlements. Yeah, you read that right. When you combine both of these, we're talking about a scenario where 3M might be forced to slash its dividend just to stay afloat. And that's the kicker - if they cut the dividend, they lose the dividend aristocrat designation. It's not just a label either; it affects how institutional investors view the stock. Wolfe Research already slashed their price target to $92, and the consensus has turned pretty bearish. The payout ratio is currently healthy at 63%, but that math changes dramatically once these settlements hit the books. Now, there's one potential lifeline - 3M is spinning off its healthcare business as a separate public company. They're looking to retain about 19.9% and could pull in over 3.2 billion from that deal. Plus, the healthcare unit is supposed to pay out a one-time dividend of 6.7 billion to the parent. That's real cash coming in. But here's where it gets tricky - even with that cash injection, analysts don't think it'll be enough to cover both the litigation costs and maintain the current dividend level. RBC Capital's take is that post-spin-off, 3M becomes a smaller company with lower dividend payouts, and yeah, probably loses that dividend aristocrat crown. The stock is down 14% year-to-date, and honestly, the litigation overhang is the main reason. If you're considering MMM for that dividend income, you might want to wait and see how these settlements actually play out. The dividend aristocrat status could be on borrowed time.
0
0
0
0